公开(公告)号：EP3167893A4

公开(公告)日：2017-09-13

申请号：EP15806181

申请日：2015-06-12

申请人： JCREATION ,  JUNG WOO CHANG

发明人： CHOUNG SE YOUNG ,  KIM DONG JOON ,  YANG SEUNG WON ,  CHOI SANG HO ,  KANG DO HYUNG ,  HEO SOO JIN

IPC分类号： A61K35/748 ,  A61P27/00 ,  A61P27/02

CPC分类号： A61K35/748 ,  A23L33/105 ,  A23V2002/00 ,  A61K38/164 ,  A61K2236/00

摘要： A Spirulina maxima extract of the present invention and Allophycocyanin (APC), R-phycoerythrin (R-PE), and C-phycocyanin (C-PC), which are components of the Spirulina maxima extract, show an effect of inhibiting cell death and A2E (pyridinium bis-retinoid), which is oxidized with a blue light, so that the present invention can be usefully applied as an active ingredient in a composition for preventing and treating retinal diseases.

摘要翻译： 作为螺旋藻提取物的组分的本发明的螺旋藻最大提取物和别藻蓝蛋白（APC），R-藻红蛋白（R-PE）和C-藻蓝蛋白（C-PC）显示出抑制细胞死亡的效果和 用蓝光氧化的A2E（吡啶双 - 类维生素A），因此本发明可有效地用作预防和治疗视网膜疾病的组合物中的活性成分。

公开(公告)号：EP3167893A1

公开(公告)日：2017-05-17

申请号：EP15806181.2

申请日：2015-06-12

申请人： JCREATION ,  Jung, Woo Chang

发明人： CHOUNG, Se Young ,  KIM, Dong Joon ,  YANG, Seung Won ,  CHOI, Sang Ho ,  KANG, Do Hyung ,  HEO, Soo Jin

IPC分类号： A61K36/02 ,  A61P27/02 ,  A61P27/00

CPC分类号： A61K35/748 ,  A23L33/105 ,  A23V2002/00 ,  A61K38/164 ,  A61K2236/00

摘要： A Spirulina maxima extract of the present invention and Allophycocyanin (APC), R-phycoerythrin (R-PE), and C-phycocyanin (C-PC), which are components of the Spirulina maxima extract, show an effect of inhibiting cell death and A2E (pyridinium bis-retinoid), which is oxidized with a blue light, so that the present invention can be usefully applied as an active ingredient in a composition for preventing and treating retinal diseases.

摘要翻译： 本发明和别藻蓝蛋白（APC），R-藻红蛋白（R-PE），和C-藻蓝蛋白（C-PC），其上的抑制性细胞死亡效果和螺旋藻提取物，显示的部件的极大螺旋藻提取物 A2E（吡啶鎓双类视黄醇），所有这些被氧化以蓝色光，所以没有本发明可被有效地应用作为活性成分的组合物中用于预防和治疗视网膜疾病。

公开(公告)号：EP3804739A1

公开(公告)日：2021-04-14

申请号：EP19812460.4

申请日：2019-05-20

申请人： Newtree Co., Ltd. ,  Jung, Woo Chang

发明人： KIM, Do Un ,  CHUNG, Hee Chul ,  JUNG, Woo Chang

IPC分类号： A61K36/28 ,  A23L33/105 ,  A61K8/9789 ,  A23K10/30 ,  A61P21/00 ,  A61Q19/00

摘要： The present invention relates to a composition comprising Aster sphathulifolius Maxim extract for preventing, improving, or treating muscular diseases and for improving muscular functions. The Aster sphathulifolius Maxim extract according to the present invention exhibits effects of inhibiting the expression of muscle protein breakdown-related factors and increasing the expression of muscle protein synthesis-related factors, as well as alleviating the reduction of muscle tissue weight and cross-sectional area of muscle fibers, and thus can be useful for preventing, improving, or treating muscular diseases and improving muscular functions.